Our second annual Access Affordability and Outcomes: The Value of Managed Care Pharmacy report is now live! The report outlines the opportunities of managed care pharmacy and how industry professionals facilitate appropriate access to prescription treatments while remaining mindful of rising costs. We developed this resource to highlight the value of managed care pharmacy and its positive impact on the health care ecosystem and patients. We hope you enjoy reading it and find it useful! https://bit.ly/4eF4eau #AAOReport #managedcare #pharmacy #AMCPResearchInstitute
关于我们
We’re the people who help patients get the medications they need at a cost they can afford. AMCP’s 8,000 members use population-level data to identify safe and cost-effective drug therapies. We optimize pharmacy benefits so that patients get the medications they need at the lowest cost.
- 网站
-
https://www.amcp.org
AMCP的外部链接
- 所属行业
- 非盈利组织
- 规模
- 11-50 人
- 总部
- Alexandria，VA
- 类型
- 非营利机构
- 创立
- 1988
- 领域
- Managed Care Pharmacy、Biosimilars、Healthcare、Payer Markets、Pharmaceuticals、PBM、Drug Costs、Pharmacists、Drug therapy、Health care economics、Continuing Education、Value Based Care、P&T和Prior Authorization
地点
-
主要
获取路线
675 N Washington Street
Suite 220
US，VA，Alexandria，22314
AMCP员工
动态
-
We appreciate you Jomy Joseph!
I want to thank the staff at AMCP under the leadership of Susan Cantrell for putting together another stellar 2024 Nexus meeting. The opportunity to gather together in this intersection of managed care pharmacy is very unique. I am very grateful to meet customers, colleagues Jason Shotwell, old friends and new ones. The content is very relevant and will challenge us to carry out mission in our workplaces. I am very encouraged by the opportunity to meet the future of managed pharmacy. Thank you for giving us a glimpse of that future - Paramjit Kaur Monali Patel, PharmD Katie Schultz Victoria Lee Iulia Opran Kamaladdin Saei Till next time!
-
-
In just under one week, the Alliance for Health Policy will host a Post-Election Symposium and Reception in Washington, D.C., bringing together the health care ecosystem to discuss the outcomes of the 2024 U.S. elections, the state of health care, and expectations for the future. Panel presentations and keynote speakers, including our own Adam Colborn, Associate Vice President of Congressional Affairs, will provide perspective on what’s ahead for health policy in the administration, Congress, and the federal courts. Interested in joining us? Learn more about the event and register today: https://bit.ly/48IOGAw
-
We're getting a head start on #GlobalBiosimilarsWeek by exploring real-world data in #biosimilar regulatory decision-making with The Evidence Base?. Check out their interview with the Biologics & Biosimilars Collective Intelligence Consortium (BBCIC)'s Cate Lockhart, PharmD, PhD. https://bit.ly/3O1vHHL
In this interview, we speak with Cate Lockhart, PharmD, PhD (AMCP and Biologics & Biosimilars Collective Intelligence Consortium (BBCIC)) about the?poster?being presented at ISPOR—The Professional Society for Health Economics and Outcomes Research Europe 2024 ‘The Potential of Real-World Data for Informing FDA Biosimilar and Interchangeable Biosimilar Regulatory Decisions: Recommendations From a Multi-Stakeholder Expert Panel’. Read at The Evidence Base? #rwe #rwd #realworldevidence #realworlddata?#ISPOREurope2024
Expert perspectives on the potential of real-world data in biosimilar regulatory decision-making: an interview with Cate Lockhart, Biologics and Biosimilars Collective Intelligence Consortium | Becaris Publishing
becarispublishing.com
-
Don't forget to RSVP for the AMCP Executive Fellowship information session next week on Nov. 14th from 5-6 pm EST featuring our CEO, Susan Cantrell, and past AMCP fellows. Scan the QR code below to RSVP or through this link: https://lnkd.in/eYFNDs-3.
-
-
GLP-1 therapies are a trending topic for many Americans struggling with obesity and weight loss. And with each development comes new questions from usage to affordability. Learn more about these new breakthroughs through AMCP's GLP-1 FAQs: https://bit.ly/3Uh7sZN #GLP1 #ManagedCare #Pharmacy
-
-
The clinical and economic impact of coronary artery disease (CAD) underscores the need for precise and prompt diagnosis. Current imaging methods face challenges that may lead to inconclusive results, affecting diagnosis and health care resource utilization. On Nov. 12 attend The Heart Matters: Advances in Cardiac PET-MPI presented by GE HealthCare for an in-depth look at CAD diagnostic imaging, disease burden, and the limitations of current Myocardial Perfusion Imaging (MPI) in the U.S. Reserve your spot now for the webinar: https://bit.ly/3NTREZh #managedcare #pharmacy #healthcare
-
-
Fall into the season of giving by getting a jumpstart on #GivingTuesday! ?? The global generosity movement is fast approaching on Dec. 3. Maximize #AMCPFdn’s ability to inspire the next generation of managed care pharmacists through rewarding managed care programs by donating early: https://bit.ly/461HAnB #philanthropy #nonprofit #donate
-
-
Unlock complimentary continuing education credits as you delve into the critical health disparities of sickle cell disease from a payer's perspective. Discover this insightful on-demand session at AMCP Learn today! https://bit.ly/3At6EtU #sicklecell #managedcare #healthcare #pharmacy
-